1 Dean, M., "Tumour stem cells and drug resistance" 5 : 275-284, 2005
2 Dent, R., "Triple-negative breast cancer : clinical features and patterns of recurrence" 13 : 4429-4434, 2007
3 Carey, L. A., "The triple negative paradox : primary tumor chemosensitivity of breast cancer subtypes" 13 : 2329-2334, 2007
4 Swanson, S. M., "The growth hormone-deficient Spontaneous Dwarf rat is resistant to chemically induced mammary carcinogenesis" 23 : 977-982, 2002
5 Divisova, J., "The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growth" 98 : 315-327, 2006
6 Brooks, A. J., "The growth hormone receptor : mechanism of activation and clinical implications" 6 : 515-525, 2010
7 Hollier, B. G., "The epithelial-to-mesenchymal transition and cancer stem cells : a coalition against cancer therapies" 14 : 29-43, 2009
8 Kaulsay, K. K., "The effects of autocrine human growth hormone(hGH)on human mammary carcinoma cell behavior are mediated via the hGH receptor" 142 : 767-777, 2001
9 Perry, J. K., "The contribution of growth hormone to mammary neoplasia" 13 : 131-145, 2008
10 Cortes, J., "Targeting the microtubules in breast cancer beyond taxanes : the epothilones" 12 : 271-280, 2007
1 Dean, M., "Tumour stem cells and drug resistance" 5 : 275-284, 2005
2 Dent, R., "Triple-negative breast cancer : clinical features and patterns of recurrence" 13 : 4429-4434, 2007
3 Carey, L. A., "The triple negative paradox : primary tumor chemosensitivity of breast cancer subtypes" 13 : 2329-2334, 2007
4 Swanson, S. M., "The growth hormone-deficient Spontaneous Dwarf rat is resistant to chemically induced mammary carcinogenesis" 23 : 977-982, 2002
5 Divisova, J., "The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growth" 98 : 315-327, 2006
6 Brooks, A. J., "The growth hormone receptor : mechanism of activation and clinical implications" 6 : 515-525, 2010
7 Hollier, B. G., "The epithelial-to-mesenchymal transition and cancer stem cells : a coalition against cancer therapies" 14 : 29-43, 2009
8 Kaulsay, K. K., "The effects of autocrine human growth hormone(hGH)on human mammary carcinoma cell behavior are mediated via the hGH receptor" 142 : 767-777, 2001
9 Perry, J. K., "The contribution of growth hormone to mammary neoplasia" 13 : 131-145, 2008
10 Cortes, J., "Targeting the microtubules in breast cancer beyond taxanes : the epothilones" 12 : 271-280, 2007
11 Yang, J., "Sustained growth in primary culture of normal mammary epithelial cells embedded in collagen gels" 77 : 2088-2092, 1980
12 Tang, J. Z., "STAT3alpha is oncogenic for endometrial carcinoma cells and mediates the oncogenic effects of autocrine human growth hormone" 151 : 4133-4145, 2010
13 Mao, Q., "Role of the breast cancer resistance protein(BCRP/ABCG2)in drug transport-an update" 17 : 65-82, 2015
14 Mao, Q., "Role of the breast cancer resistance protein(ABCG2)in drug transport" 7 : E118-E133, 2005
15 Subramani, R., "Role of growth hormone in breast cancer" 158 : 1543-1555, 2017
16 Wu, A. M., "Role of STAT5 and epigenetics in lactation-associated upregulation of multidrug transporter ABCG2 in the mammary gland" 307 : E596-E610, 2014
17 Sorlie, T., "Repeated observation of breast tumor subtypes in independent gene expression data sets" 100 : 8418-8423, 2003
18 Ikeno, Y., "Reduced incidence and delayed occurrence of fatal neoplastic diseases in growth hormone receptor/binding protein knockout mice" 64 : 522-529, 2009
19 Yang, J., "Primary culture of human mammary epithelial cells embedded in collagen gels" 65 : 337-343, 1980
20 Mosly, D., "Predictive markers of endocrine response in breast cancer" 8 : 1-7, 2018
21 Mukhina, S., "Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormone" 101 : 15166-15171, 2004
22 Arumugam, A., "Parity and short-term estradiol treatment utilizes similar cellular mechanisms to confer protection against breast cancer" 34 : 491-505, 2014
23 Paridaens, R., "Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer : a European Organization for Research and Treatment of Cancer Randomized Study with cross-over" 18 : 724-733, 2000
24 Rhodes, D. R., "ONCOMINE : a cancer microarray database and integrated data-mining platform" 6 : 1-6, 2004
25 Arumugam, A., "Neem leaf extract inhibits mammary carcinogenesis by altering cell proliferation, apoptosis, and angiogenesis" 15 : 26-34, 2014
26 Han, B., "Multidrug resistance in cancer chemotherapy and xenobiotic protection mediated by the half ATP-binding cassette transporter ABCG2" 4 : 31-42, 2004
27 Stacy, A. E., "Molecular pharmacology of ABCG2 and its role in chemoresistance" 84 : 655-669, 2013
28 Rivera, E., "Management of metastatic breast cancer : monotherapy options for patients resistant to anthracyclines and taxanes" 33 : 176-185, 2010
29 Walia, V., "Loss of breast epithelial marker hCLCA2 promotes epithelial-tomesenchymal transition and indicates higher risk of metastasis" 31 : 2237-2246, 2012
30 Beckwith, H., "Insulin-like growth factors, insulin, and growth hormone signaling in breast cancer : implications for targeted therapy" 20 : 1214-1221, 2014
31 Wu, A. M., "Induction of multidrug resistance transporter ABCG2by prolactin in human breast cancer cells" 83 : 377-388, 2013
32 Ansieau, S., "Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence" 14 : 79-89, 2008
33 Murphy, C. G., "Holding back the sea : the role for maintenance chemotherapy in metastatic breast cancer" 122 : 177-179, 2010
34 Gebre-Medhin, M., "Growth hormone receptor is expressed in human breast cancer" 158 : 1217-1222, 2001
35 Guevara-Aguirre, J., "Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans" 3 : 70ra13-, 2011
36 Minoia, M., "Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression" 97 : E907-E916, 2012
37 Felice, D. L., "Growth hormone potentiates 17beta-estradiol-dependent breast cancer cell proliferation independently of IGF-I receptor signaling" 154 : 3219-3227, 2013
38 Zatelli, M. C., "Growth hormone excess promotes breast cancer chemoresistance" 94 : 3931-3938, 2009
39 Sorlie, T., "Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications" 98 : 10869-10874, 2001
40 O’Shaughnessy, J., "Extending survival with chemotherapy in metastatic breast cancer" 10 (10): 20–29-, 2005
41 Kopchick, J. J., "Evaluation of growth hormone(GH)action in mice : discovery of GH receptor antagonists and clinical indications" 386 : 34-45, 2014
42 Hess, K. R., "Estrogen receptors and distinct patterns of breast cancer relapse" 78 : 105-118, 2003
43 Berry, D. A., "Effect of screening and adjuvant therapy on mortality from breast cancer" 353 : 1784-1792, 2005
44 Shin, S., "ERK2 but not ERK1induces epithelial-to-mesenchymal transformation via DEF motif-dependent signaling events" 38 : 114-127, 2010
45 Yu, F., "Breast cancer prognosis signature: linking risk stratification to disease subtypes" 2018
46 Zekri, A., "Autocrine human growth hormone increases sensitivity of mammary carcinoma cell to arsenic trioxide-induced apoptosis" 377 : 84-92, 2013